Condition category
Musculoskeletal Diseases
Date applied
19/09/2014
Date assigned
29/06/2015
Last edited
29/06/2015
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
Osteoarthritis (OA) is a condition that causes the joints to become painful and stiff. People with knee OA suffer from pain during normal activities such as walking, standing or climbing stairs, so they reduce their overall activity in order to minimise the pain. Using lateral wedge insoles in their shoes can reduce patients’ pain by decreasing the weight which is transmitted through their knee joint. The aim of the study is to find out whether a lateral wedged insole improves activity levels in patients with medial knee OA.

Who can participate?
Participants aged 40-85 suffering from OA and on the waiting list for surgery.

What does the study involve?
Participants with knee OA will be randomly allocated into two groups, to wear either lateral wedged insoles or neutral insoles for six weeks. Knee loading, level of physical activity, knee pain, physical function and balance will be measured.

What are the possible benefits and risks of participate?
There will be no immediate direct benefits to those taking part as the result will help future practice with insoles. However, wearing insoles for six weeks may decrease knee pain and increase comfort when walking. There are no risks with using insoles or during the study. Using the activPAL device (to monitor the level of physical activity) is completely safe as this has been used many times previously and it is comfortable to wear for the participants.

Where is the study run from?
The study will be performed in the gait laboratory at the University of Salford (UK).

When is the study staring and how long is it expected to run for?
From May 2015 until June 2016.

Who is funding the study?
1. University of Salford (UK)
2. King Saud Medical City (Saudi Arabia)

Who is the main contact?
Professor Richard Jones, r.k.jones@salford.ac.uk
Mr Yasser Althebaity, y.m.althebaity@edu.salford.ac.uk

Trial website

Contact information

Type

Scientific

Primary contact

Mr Yasser Althebaity

ORCID ID

Contact details

PO36 Brian Blatchford Building
University of Salford
Salford
M6 6PU
United Kingdom
+44 (0)161 295 2295
y.m.althebaity@edu.salford.ac

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

062015

Study information

Scientific title

The effectiveness of a lateral Wedge insole on osteoarthritis Pain, Activity level and joint Loading: a pilot study

Acronym

WPAL Study

Study hypothesis

The external knee adduction moment (knee loading) will decrease in the group using the lateral wedged insole. Whereas, level of physical activity, knee pain, dynamic balance, and physical function will improve in the group using the lateral wedged insole. In addition, it is hypothesised that reduction in knee loading will lead to a corresponding increase in activity level in comparison to the comparator group.

Ethics approval

1. Ethical Approval Panel, the University of Salford, 04/06/2014, ref: HSCR14/24
2. NHS ethics approval: not provided at time of registration.

Study design

Randomised pilot study

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Treatment

Patient information sheet

Not available in web format, please contact the principle investigator to request a participant information sheet.

Condition

Medial knee osteoarthritis

Intervention

Patients are randomised to two groups: lateral wedged insole group, and neutral insole group. Participants will wear those insoles for six weeks

Intervention type

Phase

Not Applicable

Drug names

Primary outcome measures

1. Level of physical activity
2. External knee adduction moment (EKAM)
3. Pain level

Outcomes will be measured in four different specific period of time (pre- intervention, baseline, during intervention, post-intervention) to find out any change in these outcomes compare to the baseline’s findings.

Secondary outcome measures

1. Dynamic balance
2. Knee injury and Osteoarthritis Outcome Score (KOOS) other items
3. Physical Activity Score for the Elderly (PASE)
4. Aggregated Locomotor Function (ALF) score
5. 12-item Short-Form Health Survey (SF-12)

Overall trial start date

01/05/2015

Overall trial end date

30/06/2016

Reason abandoned

Eligibility

Participant inclusion criteria

1. Age 40-85
2. Pain with walking.
3. Participants have been diagnosed with mild-moderate medial knee OA by GP based on the clinical and radiographic criteria
4. On AP or PA view x-ray (weight bearing, if possible) within the last 2 years of screening. Therefore, for a patient to be eligible on x-ray they must fulfil the following criteria
4.1. KL grade 2 or 3 in the tibiofemoral joint (TFJ)
4.2. The KL grade in the TFJ must be higher than the PFJ and cannot be equal
4.3. The medial joint space narrowing score must be higher that the lateral joint space narrowing score and cannot be equal
5. Medial tenderness. Absence of PF tenderness on examination.
6. They are able to walk for 100 metres non-stop - participant response.
7. Can walk without any walking aid.

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

30 participants with medial knee OA.

Participant exclusion criteria

1. A history of high tibial osteotomy or other realignment surgery or total knee replacement on the affected side
2. Knee Arthroscopy with the last 6 months
3. Intra-articular injection into the treatment knee in the last 3 months.
4. Inflammatory arthritis including Rheumatoid Arthritis
5. Complex pain conditions such as fibromyalgia
6. Any foot and ankle problems
7. Severe coexisting medical morbidities,
8. Use, or have used, orthoses within the last 2 months.
9. BMI >35 since gait laboratory cannot perform accurate measurements.
10. Unable to walk unaided.
If the participants cannot walk for 100 metres without stopping they will also be excluded, as they may be unable to complete the full testing protocol.

Recruitment start date

01/05/2015

Recruitment end date

30/06/2016

Locations

Countries of recruitment

United Kingdom

Trial participating centre

PO36 Brian Blatchford Building
Salford
M6 6PU
United Kingdom

Sponsor information

Organisation

University of Salford (UK)

Sponsor details

PO42 Brian Blatchford Building
A6
Salford
M6 6PU
United Kingdom
-
r.k.jones@salford.ac.uk

Sponsor type

University/education

Website

http://.salford.ac.uk

Funders

Funder type

University/education

Funder name

University of Salford (UK)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

King Saud Medical City (Saudi Arabia)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes